全文获取类型
收费全文 | 9233篇 |
免费 | 437篇 |
国内免费 | 90篇 |
专业分类
耳鼻咽喉 | 95篇 |
儿科学 | 184篇 |
妇产科学 | 280篇 |
基础医学 | 1130篇 |
口腔科学 | 153篇 |
临床医学 | 749篇 |
内科学 | 2392篇 |
皮肤病学 | 119篇 |
神经病学 | 875篇 |
特种医学 | 450篇 |
外科学 | 1340篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 392篇 |
眼科学 | 97篇 |
药学 | 547篇 |
中国医学 | 16篇 |
肿瘤学 | 919篇 |
出版年
2023年 | 73篇 |
2022年 | 143篇 |
2021年 | 247篇 |
2020年 | 179篇 |
2019年 | 187篇 |
2018年 | 221篇 |
2017年 | 181篇 |
2016年 | 224篇 |
2015年 | 241篇 |
2014年 | 309篇 |
2013年 | 393篇 |
2012年 | 682篇 |
2011年 | 681篇 |
2010年 | 378篇 |
2009年 | 370篇 |
2008年 | 610篇 |
2007年 | 586篇 |
2006年 | 556篇 |
2005年 | 562篇 |
2004年 | 492篇 |
2003年 | 452篇 |
2002年 | 443篇 |
2001年 | 125篇 |
2000年 | 125篇 |
1999年 | 112篇 |
1998年 | 100篇 |
1997年 | 84篇 |
1996年 | 65篇 |
1995年 | 57篇 |
1994年 | 46篇 |
1993年 | 48篇 |
1992年 | 85篇 |
1991年 | 64篇 |
1990年 | 89篇 |
1989年 | 83篇 |
1988年 | 50篇 |
1987年 | 56篇 |
1986年 | 43篇 |
1985年 | 44篇 |
1984年 | 23篇 |
1983年 | 29篇 |
1982年 | 17篇 |
1980年 | 25篇 |
1979年 | 21篇 |
1977年 | 10篇 |
1976年 | 13篇 |
1974年 | 10篇 |
1973年 | 11篇 |
1971年 | 14篇 |
1968年 | 10篇 |
排序方式: 共有9760条查询结果,搜索用时 31 毫秒
61.
Domenico Schiavino Eleonora Nucera Emanuela Pollastrini Tiziana De Pasquale Alessandro Buonomo Francesco Bartolozzi Carla Lombardo Chiara Roncallo Giampiero Patriarca 《Annals of allergy, asthma & immunology》2004,92(4):409-413
BACKGROUND: Hymenoptera venom hypersensitivity is an epidemiologically important problem. The only effective treatment in the management of venom-allergic patients with a history of generalized reactions to insect sting is specific immunotherapy. OBJECTIVE: To demonstrate safety and effectiveness of a modified ultrarush desensitization protocol in venom-allergic patients. METHODS: Fifty-seven patients with Hymenoptera venom allergy underwent a specific 1-day ultrarush desensitization by the subcutaneous route, reaching the cumulative dose of 101.1 microg in 2.5 hours. The maintenance dose (100 microg) was administered after 15 days and thereafter once a month. Patients were followed up for a year. Antihistamines were withheld for 15 days before and during desensitization to not underestimate the incidence of adverse effects. RESULTS: All patients but I completed the ultrarush desensitization. (This patient discontinued the treatment because of a hypertensive crisis not related to the desensitization.) The treatment caused a rapid variation of immunological parameters (IgE, IgG4) since the 15th day. After the desensitization, skin prick test results became negative in 15 patients (27%, decrease of 3.5 log), whereas they decreased in 14 patients (25%, decrease of 1 log). Sixty-four percent showed no adverse effects. Only 7% had a mild systemic reaction. CONCLUSIONS: Ultrarush desensitization is an effective and safe therapy in the management of patients with Hymenoptera venom allergy. In fact, it provides a faster tolerance, without significant differences regarding incidence of severe adverse effects, compared with traditional and rush protocols. It can be adopted for all patients, even children and teenagers. 相似文献
62.
Domenico Rosace Cristina Gomez-Casado Paloma Fernandez Marina Perez-Gordo María del Carmen Dominguez Angel Vega María Teresa Belver Tania Ramos Francisco Vega Guadalupe Marco Manuel de Pedro Leticia Sanchez María de las Mercedes Arnas Marcela Santaolalla Miguel Ángel Saez Sara Benedé Montserrat Fernandez-Rivas Carlos Blanco Domingo Barber 《The Journal of allergy and clinical immunology》2019,143(2):681-690.e1
63.
Calogero Caruso Giuseppina Candore Diego Cigna Gabriele Di Lorenzo Guido Sireci Francesco Dieli Alfredo Salerno 《Immunologic research》1996,15(1):84-90
It is well known that aging is associated with various alterations in lymphoid cell functions, particularly with a progressive decline in immune responsiveness to exogenous antigens and increasing incidence of autoimmune phenomena. Many studies have been focused on the mechanisms of the immunologic features of aging. This review describes our results of studies performed to determine the influence of age on the capacity to produce interleukin-2 (IL-2), interferon-γ (IFN-γ), interleukin-4 (IL-4), interleukin-5 (IL-5), interleukin-6 (IL-6) and tumor necrosis factor (TNF). Mitogen-stimulated cultures of mononuclear cells (MNC) from human beings were assessed for cytokine-producing capacity. A significant decrease in IFN-γ and IL-2 production by MNC cultures from elderly individuals was observed. No significant difference was instead observed between cultures from elderly individuals and those from young ones as regards TNF-α, IL-4 and IL-6 production. Mitogen or antigen-stimulated cultures of MNC from aged mice also displayed a significant decrease in IFN-γ and IL-2 production as well as TNF-β. Instead IL-4 and IL-5 production significantly increased in these cultures. We suggest that this imbalanced cytokine production may well account for the pattern of immune response which may be observed in the elderly, i.e. a normal or increased humoral response (including autoimmune responses) in face of a low T cell immune responsiveness. 相似文献
64.
Domenico Ribatti Renato Contino Fabio Quondamatteo Vittoria Formica Alfredo Tursi 《Anatomy and embryology》1992,186(3):241-244
Summary Two mast cell populations, connective tissue mast cells (CTMCs) and mucosal mast cells, (MMCs) containing different proteoglycans in their granules, can be distinguished in several animal species by means of histochemical methods. In this study we documented the presence of these two types of mast cell in the chick embryo lung, from the 15th incubation day for the MMCs, and from the 18th incubation day for the CTMCs. Lungs of embryos treated with compound 48/ 80, which produces degranulation of the CTMCs, showed a decrease in the number of this type of mast cell and an unchanged number of MMCs. In the lungs of embryos treated with dexamethasone, which degranulates MMCs, a reduction in the number of these cells and an unchanged number of the CTMs were found. 相似文献
65.
Vancheri C Gili E Failla M Mastruzzo C Salinaro ET Lofurno D Pistorio MP La Rosa C Caruso M Crimi N 《The Journal of allergy and clinical immunology》2005,116(6):1242-1248
BACKGROUND: The identification of factors mediating the transition of lung fibroblasts into myofibroblasts is considered fundamental in the comprehension of abnormal reparative processes. Bradykinin, a mediator known for its proinflammatory action, is able to induce cytokine production and contractility in fibroblast cultures. OBJECTIVES: In this study the ability of bradykinin to drive fibroblast into a myofibroblast phenotype at the cellular and molecular level was evaluated. METHODS: alpha-Smooth muscle actin (alpha-SMA) expression and TGF-beta in bradykinin stimulated fibroblasts were tested by means of flow cytometry, Western blot, and RT-PCR. Cell proliferation and collagen production were evaluated by the colorimetric methylthiazol tetrazolium assay and sirius red assay, respectively. Which bradykinin receptor mediates the expression of alpha-SMA was evaluated using selective B1 and B2 blocking agents. Furthermore, the effect of bradykinin on extracellular signal-regulated kinase 1/2 phosphorylation was explored. RESULTS: Bradykinin caused in lung fibroblasts a significant increase in alpha-SMA at the cellular and molecular level. The B2 receptor was held responsible for this effect because a specific receptor antagonist had entirely blocked this effect. Bradykinin was able to induce fibroblast proliferation and collagen production. Bradykinin significantly activated mitogen-activated protein kinase pathway by phosphorylating extracellular signal-regulated kinase 1/2, whereas PD98059, a specific inhibitor, was able to block myofibroblast induction. Although bradykinin induced an increase of TGF-beta on fibroblasts, the blockage of this cytokine did not alter alpha-SMA expression. CONCLUSION: The data support the hypothesis that bradykinin may be involved in bronchial remodeling and lung fibrosis beyond its well recognized proinflammatory activity, also suggesting a new potential therapeutic strategy to control altered reparatory processes. 相似文献
66.
Aneruptive fever associated with antibodies to Rickettsia helvetica in Europe and Thailand
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Fournier PE Allombert C Supputamongkol Y Caruso G Brouqui P Raoult D 《Journal of clinical microbiology》2004,42(2):816-818
We report that eight patients from France, Italy, and Thailand had serological evidence of Rickettsia helvetica infection. The infection presented as a mild disease in the warm season and was associated with fever, headache, and myalgia but not with a cutaneous rash. R. helvetica should be suspected in patients with unexplained fever, especially following a bite from an Ixodes sp. tick. 相似文献
67.
68.
Alessi N Freni MA Spadaro A Ajello A Turiano S Migliorato D Ferraù O 《Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive》2003,11(4):208-212
The aim of this study was to evaluate the efficacy and tolerability of interferon treatment in aged patients with chronic hepatitis C. One hundred and fifty-four patients with chronic hepatitis C, consecutively treated with a-interferon (a-IFN), were retrospectively subdivided into two groups according to age =60 or <60 years. The two groups were compared in terms of biochemical and histological activity of the disease, HCV genotype, total dose of IFN received, incidence of side effects and rate of response to treatment. Statistical analysis was performed by Student's t test, chi-square test and Fisher's exact test. Aged patients had a higher prevalence of HCV genotype 1b and cirrhosis and received a lower dose of the drug. No differences were found in other epidemiological-clinical characteristics before treatment. The rate of sustained response and long-term response to therapy was similar in the two groups of patients (18% and 8% in the aged and 20% and 13% in the younger respectively). There was a trend of more frequent major side effects in aged patients (p=0.07). Treatment of chronic hepatitis C with a-IFN had the same efficacy in the two groups observed. In aged patients with chronic hepatitis C treatment with the more effective pegylated IFN should be taken into consideration, especially when association with ribavirin is at high risk of adverse events. 相似文献
69.
Paola Origone Carlo Bellini Debora Sambarino Barbara Banelli Guido Morcaldi Carmen La Rosa Franco Stanzial Claudio Castellan Domenico A. Coviello Cecilia Garrè Eugenio Bonioli 《Human mutation》2003,22(4):341-341
In the original version of this article, the title was incorrect. Please find the correct title given here. The publisher deeply regrets this error. The original article to which this Erratum refers was published in Human Mutation 22:179–180 Human Mutation(2003) 22(2) 179–180 相似文献
70.
Giuseppe Giuffrè Rosario Alberto Caruso Gaetano Barresi G. Tuccari 《Virchows Archiv : an international journal of pathology》1998,432(3):261-266
To assess the prognostic significance of silver-stained nucleolar organizer region (AgNOR) proteins, a standardized AgNOR
analysis was performed on 78 patients affected by early (EGC, n=24) or advanced (AGC, n=54) gastric carcinomas. The histopathological diagnosis, grading and staging were done according to WHO and UICC recommendations;
the mean follow-up time was 56.9 months. Visualization and quantification of AgNORs were made in formalin-fixed, paraffin-embedded
sections as specified in the guidelines of the Committee on AgNOR Quantification (1995). Statistical analysis was performed
on the mean AgNOR area values (NORA). Highly significant differences (P<0.001) were found in NORA values between EGC and AGC, between low- and high-grade gastric carcinomas and between patients
dead from gastric cancer and living patients. In addition, significant P values were found on comparison of NORA values relating to pT status, pN status and stage. Comparison of Kaplan-Meier survival
curves revealed that patients affected by gastric carcinomas with higher NORA values (>5.213 μm2) had a worse prognosis. Finally, using Cox multiple regression analysis, the AgNOR quantity emerged as a useful independent
prognostic variable to predict the final outcome of patients affected by EGC or AGC.
Received: 26 September 1997 / Accepted: 26 January 1998 相似文献